In a study conducted in 112 high risk acute leukemia patients undergoing haplotype mismatched HSCT, the probability of event-free survival at 5 years was significantly higher in KIR mismatched group compared to KIR matched group (60% vs. <5%, p < 0.0005) [77]. The gene discussed is KIR3DL1; the disease is acute leukemia.